|
R3HDM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.945410E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.981900E-02 |
| Normal-vs-Stage2 |
8.799200E-01 |
| Normal-vs-Stage3 |
7.613600E-01 |
| Normal-vs-Stage4 |
5.077200E-01 |
| Stage1-vs-Stage2 |
3.465200E-01 |
| Stage1-vs-Stage3 |
1.164550E-01 |
| Stage1-vs-Stage4 |
2.430600E-01 |
| Stage2-vs-Stage3 |
7.371000E-01 |
| Stage2-vs-Stage4 |
4.410600E-01 |
| Stage3-vs-Stage4 |
5.642200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.095500E-02 |
| Normal-vs-AfricanAmerican |
8.397800E-01 |
| Normal-vs-Asian |
5.995400E-01 |
| Caucasian-vs-AfricanAmerican |
2.851400E-01 |
| Caucasian-vs-Asian |
3.612200E-01 |
| AfricanAmerican-vs-Asian |
6.241000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.523400E-03 |
| Normal-vs-Female |
2.094100E-02 |
| Male-vs-Female |
1.72643999999389E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.874400E-01 |
| Normal-vs-Extreme_Weight |
3.350900E-04 |
| Normal-vs-Obese |
9.169200E-01 |
| Normal-vs-Extreme_Obese |
1.497370E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.849440E-01 |
| Normal_Weight-vs-Obese |
3.151000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.799800E-01 |
| Extreme_Weight-vs-Obese |
4.721000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.765200E-01 |
| Obese-vs-Extreme_Obese |
1.752640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.171900E-02 |
| Normal-vs-Age(41-60Yrs) |
8.442400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.757000E-03 |
| Normal-vs-Age(81-100Yrs) |
3.658000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.888400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.220690E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.560300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.385000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.379700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.498000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.152200E-02 |
| Normal-VS-Type2 PRCC |
1.203200E-01 |
| Normal-VS-KIRP CIMP |
2.151600E-02 |
| Normal-VS-Unclassified PRCC |
4.409000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.425400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.6933999999953E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.478400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.417230E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.352200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.492000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.164000E-02 |
| Normal-vs-N1 |
6.287600E-02 |
| Normal-vs-N2 |
6.809400E-01 |
| N0-vs-N1 |
6.183900E-03 |
| N0-vs-N2 |
2.324400E-01 |
| N1-vs-N2 |
6.279200E-01 |
|
|
